Friulchem Future Growth
Future criteria checks 4/6
Friulchem is forecast to grow earnings and revenue by 106.4% and 9.3% per annum respectively. EPS is expected to grow by 105.9% per annum. Return on equity is forecast to be 6.9% in 3 years.
Key information
106.4%
Earnings growth rate
105.9%
EPS growth rate
| Pharmaceuticals earnings growth | 15.4% |
| Revenue growth rate | 9.3% |
| Future return on equity | 6.9% |
| Analyst coverage | Low |
| Last updated | 19 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 38 | 1 | 1 | N/A | 1 |
| 12/31/2025 | 35 | 1 | 0 | N/A | 1 |
| 12/31/2024 | 31 | 0 | -4 | N/A | 1 |
| 6/30/2024 | 31 | 0 | N/A | N/A | N/A |
| 3/31/2024 | 31 | 0 | N/A | N/A | N/A |
| 12/31/2023 | 31 | 0 | N/A | N/A | N/A |
| 9/30/2023 | 33 | 0 | N/A | N/A | N/A |
| 6/30/2023 | 34 | 0 | -8 | -6 | N/A |
| 3/31/2023 | 35 | 0 | -6 | -4 | N/A |
| 12/31/2022 | 36 | 0 | -3 | -1 | N/A |
| 9/30/2022 | 34 | 0 | N/A | N/A | N/A |
| 6/30/2022 | 32 | 0 | N/A | N/A | N/A |
| 3/31/2022 | 28 | 0 | N/A | N/A | N/A |
| 12/31/2021 | 24 | 0 | N/A | N/A | N/A |
| 9/30/2021 | 22 | 0 | N/A | N/A | N/A |
| 6/30/2021 | 19 | 0 | N/A | N/A | N/A |
| 3/31/2021 | 18 | 0 | N/A | N/A | N/A |
| 12/31/2020 | 18 | 0 | -1 | 0 | N/A |
| 9/30/2020 | 17 | 0 | N/A | N/A | N/A |
| 6/30/2020 | 16 | 0 | -2 | 0 | N/A |
| 3/31/2020 | 16 | 0 | -1 | 1 | N/A |
| 12/31/2019 | 16 | 0 | -1 | 1 | N/A |
| 9/30/2019 | 16 | 0 | N/A | N/A | N/A |
| 6/30/2019 | 16 | 0 | N/A | N/A | N/A |
| 3/31/2019 | 16 | 0 | N/A | N/A | N/A |
| 12/31/2018 | 17 | 0 | 1 | 2 | N/A |
| 12/31/2017 | 16 | 0 | N/A | 0 | N/A |
| 12/31/2016 | 16 | 0 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FCM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: FCM is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: FCM is expected to become profitable in the next 3 years.
Revenue vs Market: FCM's revenue (9.3% per year) is forecast to grow faster than the Italian market (3.9% per year).
High Growth Revenue: FCM's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FCM's Return on Equity is forecast to be low in 3 years time (6.9%).